Acute Toxicity and 90-Day Mortality in Stage I NSCLC Patients Treated with SBRT – ESTRO

European Society for Radiotherapy and Oncology shared a post on X about a recent paper by Peter S.N. van Rossum et al. published in the Journal of Thorac Oncology:

“Real-World Acute Toxicity and 90-Day Mortality in Patients with Stage I NSCLC Treated with Stereotactic Body Radiotherapy, published in Journal of Thorac Oncology.

Read it before your patients.”

“Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy”

Authors: Peter S.N. van Rossum et al.

Acute Toxicity and 90-Day Mortality in Stage I NSCLC Patients Treated with SBRT - ESTRO